143 related articles for article (PubMed ID: 402175)
21. Inhibition of diamine oxidase by antimalarial drugs.
Ma K; Sourkes TL
Agents Actions; 1980 Nov; 10(5):395-8. PubMed ID: 6782842
[TBL] [Abstract][Full Text] [Related]
22. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
23. [Oxidation of p-nitrobenzylamine and p-dimethylaminomethylbenzylamine by amine oxidases from the human placenta and serum].
Kirkel' AZ; Romaniuk IuP; Davydova GA; Ermolaev KM; Pekkel' VA
Vopr Med Khim; 1986; 32(2):118-25. PubMed ID: 3705505
[TBL] [Abstract][Full Text] [Related]
24. Effects of monamine oxidase inhibitors on qualitive alterations ( Transformation ) of the catalytic properties of amine oxidases.
Gorkin VZ; Akopyan ZI; Veryovkina IV; Stesina LN; Samed MM
Biochem J; 1971 Feb; 121(3):31P-32P. PubMed ID: 5000918
[No Abstract] [Full Text] [Related]
25. Putrescine, a source of gamma-aminobutyric acid in the adrenal gland of the rat.
Caron PC; Cote LJ; Kremzner LT
Biochem J; 1988 Apr; 251(2):559-62. PubMed ID: 3135801
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).
Fitzgerald DH; Tipton KF
J Neural Transm (Vienna); 2002 Mar; 109(3):251-65. PubMed ID: 11956949
[TBL] [Abstract][Full Text] [Related]
27. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A
Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242
[No Abstract] [Full Text] [Related]
28. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
Baker GB; Sowa B; Todd KG
J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
[No Abstract] [Full Text] [Related]
29. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
Collins GG; Youdim MB; Sandler M
Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
[No Abstract] [Full Text] [Related]
30. Comparison of kinetic properties between plant and fungal amine oxidases.
Luhová L; Slavík L; Frébort I; Sebela M; Zajoncová L; Pec P
J Enzyme Inhib; 1996; 10(4):251-262. PubMed ID: 8872745
[TBL] [Abstract][Full Text] [Related]
31. Involvement of diamine oxidase in catabolism of 14C-putrescine in mice in vivo with special reference to the formation of gamma-aminobutyric acid.
Fogel WA; Bieganski T; Schayer RW; Maslinski C
Agents Actions; 1981 Dec; 11(6-7):679-84. PubMed ID: 6803541
[TBL] [Abstract][Full Text] [Related]
32. Diamine oxidase in the hen.
Biegański T; Ulatowska MA
Agents Actions; 1983 Apr; 13(2-3):257-62. PubMed ID: 6408912
[TBL] [Abstract][Full Text] [Related]
33. Monoamine oxidase inhibitors and other drugs as inhibitors of diamine oxidase from human placenta and pig kidney.
Crabbe MJ; Bardsley WG
Biochem Pharmacol; 1974 Nov; 23(21):2983-900. PubMed ID: 4215424
[No Abstract] [Full Text] [Related]
34. The importance of human intestinal diamine oxidase in the oxidation of histamine and/or putrescine.
Biegański T; Kusche J; Feussner KD; Hesterberg R; Richter H; Lorenz W
Arch Immunol Ther Exp (Warsz); 1980; 28(6):901-6. PubMed ID: 6114722
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of in vivo histamine metabolism in rats by foodborne and pharmacologic inhibitors of diamine oxidase, histamine N-methyltransferase, and monoamine oxidase.
Hui JY; Taylor SL
Toxicol Appl Pharmacol; 1985 Nov; 81(2):241-9. PubMed ID: 3933141
[TBL] [Abstract][Full Text] [Related]
36. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
Maître L
J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
[No Abstract] [Full Text] [Related]
37. Inhibition of diamine oxidase promotes uptake of putrescine from rat small intestine.
Nilsson BO; Kockum I; Rosengren E
Inflamm Res; 1996 Oct; 45(10):513-8. PubMed ID: 8912017
[TBL] [Abstract][Full Text] [Related]
38. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
39. The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).
Foot JS; Deodhar M; Turner CI; Yin P; van Dam EM; Silva DG; Olivieri A; Holt A; McDonald IA
Bioorg Med Chem Lett; 2012 Jun; 22(12):3935-40. PubMed ID: 22595173
[TBL] [Abstract][Full Text] [Related]
40. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
MAXWELL DR; GRAY WR; TAYLOR EM
Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
